Tenet Healthcare (NYSE:THC) Issues FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 11.740-12.840 for the period, compared to the consensus earnings per share estimate of 11.080. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $21.3 billion.

Tenet Healthcare Trading Down 6.5 %

NYSE:THC traded down $8.99 during midday trading on Wednesday, hitting $129.84. 1,534,469 shares of the company traded hands, compared to its average volume of 1,054,213. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The firm’s fifty day moving average is $133.85 and its 200-day moving average is $148.52. Tenet Healthcare has a 12-month low of $86.90 and a 12-month high of $171.20. The firm has a market capitalization of $12.35 billion, a P/E ratio of 4.16, a P/E/G ratio of 0.63 and a beta of 2.05.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. On average, sell-side analysts predict that Tenet Healthcare will post 11.37 EPS for the current year.

Analyst Ratings Changes

THC has been the topic of a number of research reports. StockNews.com lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 17th. Raymond James downgraded Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price on the stock. in a research report on Friday, November 22nd. The Goldman Sachs Group downgraded Tenet Healthcare from a “buy” rating to a “neutral” rating and decreased their target price for the company from $196.00 to $140.00 in a research report on Monday, December 16th. JPMorgan Chase & Co. restated an “overweight” rating and issued a $175.00 target price on shares of Tenet Healthcare in a research report on Tuesday, December 17th. Finally, Cantor Fitzgerald lifted their price objective on Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Three analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $165.00.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.